DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma

British Journal of Cancer

Volumn 106, Issue 2, 2012, Pages 414-423

  Brait, M ^a   Maldonado, L ^a   Begum, S ^b   Loyo, M ^a   Wehle, D ^b   Tavora, F F ^b   Looijenga, L H J ^c   Kowalski, J ^a,d   Zhang, Z ^a   Rosenbaum, E ^a,e   Halachmi, S ^f   Netto, G J ^b   Hoque, M O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^d EMORY UNIVERSITY   (United States)

^e RABIN MEDICAL CENTER   (Israel)

^f BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

biomarker; DNA methylation; epigenetics; non seminoma; seminoma; testicular cancer

Indexed keywords

APC PROTEIN; ARF PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1;

ADULT; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEMINOMA;

ADULT; COHORT STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC HETEROGENEITY; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 84856425020     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.468     Document Type: Article

References (50)

1. Al-Jehani RM, Povey S, Delhanty JD, Parrington JM (1995) Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors. Genes Chromosomes Cancer 13: 249-256
2. Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337: 242-253
3. Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, Czerniak B, Caballero OL, Westra WH, Sidransky D, Hoque MO (2008) Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 17: 2786-2794
4. Brait M, Ford JG, Papaiahgari S, Garza MA, Lee JI, Loyo M, Maldonado L, Begum S, McCaffrey L, Howerton M, Sidransky D, Emerson MR, Ahmed S, Williams CD, Hoque MO (2009) Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev 18: 2984-2991
5. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, Chang S, Brait M, Nayak CS, Jiang WW, Claybourne Q, Tokumaru Y, Lee J, Goldenberg D, Garrett-Mayer E, Goodman S, Moon CS, Koch W, Westra WH, Sidransky D, Califano JA (2008) Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 14: 97-107 (Pubitemid 351377983)
6. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 19: 1151-1159
7. Coffey J, Linger R, Pugh J, Dudakia D, SokalM, Easton DF, Timothy Bishop D, Stratton M, Huddart R, Rapley EA (2008) Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature. Genes Chromosomes Cancer 47: 34-42 (Pubitemid 350191462)
8. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845
9. Ellinger J, Albers P, Perabo FG, Muller SC, von Ruecker A, Bastian PJ (2009) CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol 182: 324-329
10. Esposito F, Boscia F, Franco R, Tornincasa M, Fusco A, Kitazawa S, Looijenga LH, Chieffi P (2010) Down-regulation of oestrogen receptorbeta associates with transcriptional co-regulator PATZ1 delocalization in human testicular seminomas. J Pathol 224: 110-120
11. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229 (Pubitemid 32695003)
12. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350-1354
13. Fiegl H, Gattringer C, Widschwendter A, Schneitter A, Ramoni A, Sarlay D, Gaugg I, Goebel G, Muller HM, Mueller-Holzner E, Marth C, Widschwendter M (2004) Methylated DNA collected by tampons-a new tool to detect endometrial cancer. Cancer Epidemiol Biomarkers Prev 13: 882-888 (Pubitemid 38737880)
14. Godmann M, Lambrot R, Kimmins S (2009) The dynamic epigenetic program in male germ cells: Its role in spermatogenesis, testis cancer, and its response to the environment. Microsc Res Tech 72: 603-619
15. Herman JG (1999) Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol 9: 359-367 (Pubitemid 29532862)
16. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870-6875 (Pubitemid 28278073)
17. Holmes Jr L., Escalante C, Garrison O, Foldi BX, Ogungbade GO, Essien EJ, Ward D (2008) Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health 122: 862-872
18. Honecker F, Wermann H, Mayer F, Gillis AJ, Stoop H, van Gurp RJ, Oechsle K, Steyerberg E, Hartmann JT, Dinjens WN, Oosterhuis JW, Bokemeyer C, Looijenga LH (2009) Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol 27: 2129-2136
19. Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F (2003) Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 22: 461-466 (Pubitemid 36194343)
20. Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D (2004) Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 64: 5511-5517 (Pubitemid 39006576)
21. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, Rosenbaum E, Ongenaert M, Yamashita K, Califano J, Westra W, van der Zee AG, Van Criekinge W, Sidransky D (2008) Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 68: 2661-2670 (Pubitemid 351556263)
22. Horwich A, Shipley J, Huddart R (2006) Testicular germ-cell cancer. Lancet 367: 754-765 (Pubitemid 43326294)
23. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300
24. Jiricny J (2006) The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7: 335-346
25. Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE, Bosl GJ, Chaganti RS, Murty VV (2002) Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer 1: 8
26. Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV (2004) Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Mol Cancer 3: 16
27. Kutanzi KR, Koturbash I, Kovalchuk O. (2010) Reversibility of premalignant estrogen-induced epigenetic changes. Cell Cycle 9: 3078-3084
28. Laffaire J, Everhard S, Idbaih A, Criniere E, Marie Y, de Reynies A, Schiappa R, Mokhtari K, Hoang-Xuan K, Sanson M, Delattre JY, Thillet J, Ducray F. (2011) Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis. Neuro Oncol 13(1): 84-98
29. Lehmann U, Celikkaya G, Hasemeier B, Langer F, Kreipe H (2002) Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Cancer Res 62: 6634-6638 (Pubitemid 35364131)
30. Lind GE, Skotheim RI, Lothe RA (2007) The epigenome of testicular germ cell tumors. Apmis 115: 1147-1160 (Pubitemid 350179475)
31. Looijenga LH (2009) Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol 218: 146-162
32. Looijenga LH, Gillis AJ, van Gurp RJ, Verkerk AJ, Oosterhuis JW (1997) X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 151: 581-590 (Pubitemid 27330078)
33. Lothe RA, Peltomaki P, Tommerup N, Fossa SD, Stenwig AE, Borresen AL, Nesland JM (1995) Molecular genetic changes in human male germ cell tumors. Lab Invest 73: 606-614
34. Lutzker SG, Barnard NJ (1998) Testicular germ cell tumors: molecular understanding and clinical implications. Mol Med Today 4: 404-411 (Pubitemid 28411035)
35. Manton KJ, Douglas ML, Netzel-Arnett S, Fitzpatrick DR, Nicol DL, Boyd AW, Clements JA, Antalis TM (2005) Hypermethylation of the 50 CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. Br J Cancer 92: 760-769 (Pubitemid 40460615)
36. Mathew S, Murty VV, Bosl GJ, Chaganti RS (1994) Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 54: 6265-6269 (Pubitemid 24378663)
37. Mostert MC, Verkerk AJ, van de Pol M, Heighway J, Marynen P, Rosenberg C, van Kessel AG, van Echten J, de Jong B, Oosterhuis JW, Looijenga LH (1998) Identification of the critical region of 12p overrepresentation in testicular germ cell tumors of adolescents and adults. Oncogene 16: 2617-2627 (Pubitemid 28264039)
38. Muller C, Readhead C, Diederichs S, Idos G, Yang R, Tidow N, Serve H, Berdel WE, Koeffler HP (2000) Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol Cell Biol 20: 3316-3329 (Pubitemid 30215043)
39. Netto GJ, Nakai Y, Nakayama M, Jadallah S, Toubaji A, Nonomura N, Albadine R, Hicks JL, Epstein JI, Yegnasubramanian S, Nelson WG, De Marzo AM (2008) Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Mod Pathol 21: 1337-1344
40. Olasz J, Mandoky L, Geczi L, Bodrogi I, Csuka O, Bak M (2005) Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Anticancer Res 25: 4319-4324 (Pubitemid 41665223)
41. Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222 (Pubitemid 40314952)
42. Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M, Takahashi T (2002) Frequent and histological typespecific inactivation of 14-3-3sigma in human lung cancers. Oncogene 21: 2418-2424 (Pubitemid 34407301)
43. Peltomaki P (1991) DNA methylation changes in human testicular cancer. Biochim Biophys Acta 1096: 187-196
44. Rajpert-De Meyts E (2006) Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12: 303-323
45. Shen L, Catalano PJ, Benson III AB, O'Dwyer P, Hamilton SR, Issa JP (2007) Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13: 6093-6098 (Pubitemid 350075067)
46. Smiraglia DJ, Szymanska J, Kraggerud SM, Lothe RA, Peltomaki P, Plass C (2002) Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21: 3909-3916 (Pubitemid 34620859)
47. Smith-Sorensen B, Lind GE, Skotheim RI, Fossa SD, Fodstad O, Stenwig AE, Jakobsen KS, Lothe RA (2002) Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer. Oncogene 21: 8878-8884 (Pubitemid 36132408)
48. Sokoloff MH, Joyce GF, Wise M (2007) Testis cancer. J Urol 177: 2030-2041 (Pubitemid 46726398)
49. Strathdee G, MacKean MJ, Illand M, Brown R (1999) A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene 18: 2335-2341 (Pubitemid 29192710)
50. Wermann H, Stoop H, Gillis AJ, Honecker F, van Gurp RJ, Ammerpohl O, Richter J, Oosterhuis JW, Bokemeyer C, Looijenga LH (2010) Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J Pathol 221: 433-442